Eliane Schutte is Xeltis Chief Executive Officer since 2018. Under her leadership, the company expanded its strategy into vascular and valve applications, closed a €10.5 million Series D financing round in 2019, secured €15 million financing from the European Investment [...]
Alexander Goemans joined Xeltis as Chief Financial Officer in November 2021. He brings to the company significant experience in strategy consulting, and investment and financial management, during which he completed numerous acquisitions, equity raises and financings. Prior to Xeltis, Alexander [...]
Dr Paulo Neves is Xeltis Vice President for Clinical and Medical Affairs. Paulo brings to Xeltis remarkable medical experience as a practicing cardiac surgeon and as a pioneering implanter of a number of cardiovascular medical devices, along with medical lead [...]
Martijn Cox, PhD, has significant experience in endogenous tissue restoration (ETR) in the cardiovascular system. Cox has been one of the key contributors to the development of Xeltis’ technology. Prior to Xeltis, Cox co-founded and led QTIS/e, a startup spun [...]
Mohammed El-Kurdi, PhD, brings to Xeltis over 20 years of experience in cardiovascular bioengineering. He specializes in understanding and controlling the interaction between biomaterial-based medical devices and the diseased cardiovascular system. His scientific work is dedicated to translating the potential [...]
Jim Oberhauser Ph.D. is Associate Director, Device and Packaging Engineering at Gilead, following time as a Medical Device Consultant and nine years at Abbott Vascular where he was a Senior Manager within Global Product Development. Whilst at Abbott Vascular he [...]
Egbert (Bert) Willem Meijer is Professor and Head of the Institute for Complex Molecular Systems at Eindhoven University of Technology. He held a number of professorships at Eindhoven University of Technology, Radboud University Nijmegen and University of California, as well [...]
Director of Research at INSERM Unité 1026 BioTis, Université de Bordeaux, Dr L'Heureux’s career began as a Postdoctoral Fellow of the American Heart Association at the Department of Bioengineering. From there he co-founded and was the Chief Scientific Officer at Cytograft Tissue [...]
Jeffrey Hubbell Ph.D. is Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago Molecular Engineering Institute. Formerly a member of the chemical engineering faculty at University of Texas and at California Institute of Technology, Hubbell was also [...]
Dr Geoffrey Gurtner is Professor of Plastic & Reconstructive Surgery and, by courtesy, Professor of Bioengineering at Stanford University School of Medicine. Further roles at Stanford University include memberships of Bio-X, Cardiovascular Institute and Stanford Cancer Institute. Gurtner’s Lab is [...]
